USP dissolution apparatus 3 (reciprocating cylinder): Instrument parameter effects on drug release from sustained release formulations

Journal of Pharmaceutical Sciences

Volumn 84, Issue 8, 1995, Pages 922-926

  Rohrs, Brian R ^a   Burch‐Clark, Darlene L ^a   Witt, Marty J ^a   Stelzer, Dennis J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADINAZOLAM MESILATE; ALPRAZOLAM; FLURBIPROFEN; IBUPROFEN;

ARTICLE; DRUG DETERMINATION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; MEDICAL INSTRUMENTATION; PHARMACEUTICS; SUSTAINED RELEASE PREPARATION;

CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DIFFUSION; IBUPROFEN; PHARMACOPOEIAS; SOLUBILITY; UNITED STATES;

EID: 0029046476     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.2600840804     Document Type: Article

References (8)

1. Comparative pH‐gradient dissolution of several oral dosage forms of iron
2. In vivo‐in vitro correlation of salbutamol release from a controlled release osmotic pump delivery system
3. A new method of dissolution in vitro, the “Bio‐Dis” apparatus: Comparison with the rotating bottle method and in vitro: In vivo correlations
4. Drug release calibrators for Apparatus 3–Collaborative study results
5. Comparison of three dissolution devices for evaluating drug release
6. Qualitative evaluation of the mechanism of release of matrix sustained release dosage forms by measurement of polymer release